Jun 29

EUROPEAN CHMP ISSUES POSITIVE OPINION ON CYMBALTA FOR THE TREATMENT OF GENERALISED ANXIETY DISORDER (Bernama via Yahoo! Malaysia News)

post Category: Hyperhidrosis news post post29 June 2008

ATTENTION EDITOR, GENERAL DESK INDIANAPOLIS, June 27 /PRNewswire-AsiaNet/ — Eli Lilly And Co (NYSE: LLY) And Boehringer Ingelheim Today Announced That The Committee For Medicinal Products For Human Use (CHMP) Of The European Medicines Agency (EMEA) Has Issued A Positive Opinion Supporting The Approval Of Cymbalta(R) (duloxetine Hydrochloride) For The Treatment Of Generalised Anxiety Disorder …

Read full story

Related Posts

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

« European Issues Positive Opinion on Eli Lilly and Company’s Cymbalta…
Funky feet? It’s not you - really »

Sorry, no comments yet.

Write Your Comment

Comment Guidelines: Basic XHTML is allowed (a href, strong, em, code). All line breaks and paragraphs will be generated automatically.

You should have a name, right? 
Your email address, I promised I won't tell it to anyone. 
If you have a web site or blog, you can type the URL right here. 
This is where you type your comments. 
Remember my information for the next time I visit.
 

Spam Protection by WP-SpamFree